| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |